SCHEMBL13664126

SCHEMBL13664126

CCCCOc1cc(C(=O)OC)c(Br)c(OCCCC)c1OCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 3/20 0.43
THRB P10828 3/20 0.43
NPSR1 Q6W5P4 2/20 0.42
GAA P10253 2/20 0.42
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PLA2G2A P14555 1/20 0.39
SMPD1 P17405 3/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11929251 0.85 THRA (0.49) THRATHRBCNR2TP53TSHR
SCHEMBL13664194 0.85 KDM4E (0.42) THRATHRBNPSR1GAAALDH1A1
SCHEMBL4304698 0.84 TSHR (0.47) GAAALDH1A1L3MBTL1SMN1; SMN2MAPT
SCHEMBL8551491 0.79 THRA (0.49) THRATHRBALDH1A1KDM4EHPGD
SCHEMBL28715731 0.79 MAOA (0.53) ALDH1A1KDM4EHPGDL3MBTL1MAPT
SCHEMBL20415948 0.78 ALDH1A1 (0.48) NPSR1GAAALDH1A1KDM4EHPGD
SCHEMBL17934383 0.78 L3MBTL1 (0.46) NPSR1GAAALDH1A1KDM4EHPGD
SCHEMBL7997525 0.77 SLC6A5 (0.50) MAPTSMPD1MEN1KMT2A
SCHEMBL12588846 0.77 SCN9A (0.41) THRATHRBGAAALDH1A1KDM4E
SCHEMBL18710473 0.77 LCK (0.51) THRATHRBNPSR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & CO., LTD. (JP) 2009-10-29 US disclosed
EP-1870403-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING -AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & COMPANY, LTD. (JP) 2007-12-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME BCAT1, BCAT2, AADAT THRA 2592/4885THRB 1700/4885NPSR1 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.